Want to see BGMS full AI Analyst Report?
Bio Green Med Solution (BGMS) Stock Statistics & Valuation Metrics
Total Valuation
Bio Green Med Solution has a market cap or net worth of $5.78M. The enterprise value is $1.30M.
- Market Cap
- $5.78M
- Enterprise Value
- $1.30M
Share Statistics
Bio Green Med Solution has 6,622,794 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 6,622,794
- Owned by Insiders
- 40.98%
- Owned by Institutions
- 0.09%
Financial Efficiency
Bio Green Med Solution’s return on equity (ROE) is -0.44 and return on invested capital (ROIC) is -122.97%.
- Return on Equity (ROE)
- -0.44
- Return on Assets (ROA)
- -0.37
- Return on Invested Capital (ROIC)
- -122.97%
- Return on Capital Employed (ROCE)
- -1.23
- Revenue Per Employee
- 62.25K
- Profits Per Employee
- -249.83K
- Employee Count
- 12
- Asset Turnover
- 0.09
- Inventory Turnover
- 0.44
Valuation Ratios
The current PE Ratio of Bio Green Med Solution is -0.25. Bio Green Med Solution’s PEG ratio is -0.00.
- PE Ratio
- -0.25
- PS Ratio
- 2.65
- PB Ratio
- 0.70
- Price to FCF
- -4.50
- Price to Operating Cash Flow
- -4.57
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Bio Green Med Solution had revenue of 747.00K and earned -3.00M in profits. Earnings per share was -6.45.
- Revenue
- 747.00K
- Gross Profit
- 138.00K
- Operating Income
- -8.43M
- Pretax Income
- -2.99M
- Net Income
- -3.00M
- EBITDA
- -8.42M
- Earnings Per Share (EPS)
- -6.45
Cash Flow
In the last 12 months, operating cash flow was -1.10M and capital expenditures -1,000, giving a free cash flow of -1.10M billion.
- Operating Cash Flow
- -1.10M
- Free Cash Flow
- -1.10M
- Free Cash Flow per Share
- -0.20
Dividends & Yields
Bio Green Med Solution pays an annual dividend of $0.15, resulting in a dividend yield of ―
- Dividend Per Share
- $0.15
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -22.22%
- Earnings Yield
- -43.92%
Stock Price Statistics
- Beta
- 0.76
- 52-Week Price Change
- -43.71%
- 50-Day Moving Average
- 0.90
- 200-Day Moving Average
- 0.95
- Relative Strength Index (RSI)
- 49.35
- Average Volume (3m)
- 72.26K
Important Dates
Bio Green Med Solution upcoming earnings date is Nov 18, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 12, 2026
- Next Earnings Date
- Nov 18, 2026
- Ex-Dividend Date
- Apr 29, 2025
Financial Position
Bio Green Med Solution as a current ratio of 4.70, with Debt / Equity ratio of 0.03%
- Current Ratio
- 4.70
- Quick Ratio
- 3.66
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.42
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Bio Green Med Solution has paid 7,000 in taxes.
- Income Tax
- 7,000
- Effective Tax Rate
- -0.00
Enterprise Valuation
Bio Green Med Solution EV to EBITDA ratio is -0.42, with an EV/FCF ratio of -1.05.
- EV to Sales
- 0.62
- EV to EBITDA
- -0.42
- EV to Free Cash Flow
- -1.05
- EV to Operating Cash Flow
- -1.05
Balance Sheet
Bio Green Med Solution has $3.79M in cash and marketable securities with $0.00 in debt, giving a net cash position of $3.79M billion.
- Cash & Marketable Securities
- $3.79M
- Total Debt
- $0.00
- Net Cash
- $3.79M
- Net Cash Per Share
- $0.57
- Tangible Book Value Per Share
- $1.00
Margins
Gross margin is 19.34%, with operating margin of -147.13%, and net profit margin of -118.27%.
- Gross Margin
- 19.34%
- Operating Margin
- -147.13%
- Pretax Margin
- -115.91%
- Net Profit Margin
- -118.27%
- EBITDA Margin
- -146.72%
- EBIT Margin
- -147.13%
Analyst Forecast
The average price target for Bio Green Med Solution is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 18510.00%
- EPS Growth Forecast
- 98.80%
Scores
- Smart Score
- ―
- AI Score
- 46
